In the latest session, ATAI Life Sciences N.V (NASDAQ: ATAI) closed at $3.33 down -6.72% from its previous closing price of $3.57. In other words, the price has decreased by -$6.72 from its previous closing price. On the day, 9.91 million shares were traded. ATAI stock price reached its highest trading level at $3.37 during the session, while it also had its lowest trading level at $3.06.
Ratios:
For a deeper understanding of ATAI Life Sciences N.V’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.07 and its Current Ratio is at 4.07. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on November 18, 2024, Reiterated its Buy rating but revised its target price to $10 from $15 previously.
On April 03, 2024, Maxim Group Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $6.
On November 01, 2022, Loop Capital started tracking the stock assigning a Buy rating and target price of $18.Loop Capital initiated its Buy rating on November 01, 2022, with a $18 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 02 ’25 when SAHIL KIRPEKAR bought 83,332 shares for $2.81 per share.
SAHIL KIRPEKAR bought 106,093 shares of ATAI for $294,381 on Jul 01 ’25. On Jun 04 ’25, another insider, SAHIL KIRPEKAR, who serves as the Officer of the company, bought 80,000 shares for $2.48 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATAI now has a Market Capitalization of 757351872 and an Enterprise Value of 598109248. For the stock, the TTM Price-to-Sale (P/S) ratio is 2025.79 while its Price-to-Book (P/B) ratio in mrq is 4.38. Its current Enterprise Value per Revenue stands at 321.046 whereas that against EBITDA is -6.214.
Stock Price History:
The Beta on a monthly basis for ATAI is 1.57, which has changed by 1.1907895 over the last 52 weeks, in comparison to a change of 0.17535925 over the same period for the S&P500. Over the past 52 weeks, ATAI has reached a high of $4.00, while it has fallen to a 52-week low of $1.03. The 50-Day Moving Average of the stock is 33.10%, while the 200-Day Moving Average is calculated to be 90.91%.
Shares Statistics:
For the past three months, ATAI has traded an average of 4.28M shares per day and 7828060 over the past ten days. A total of 199.78M shares are outstanding, with a floating share count of 137.08M. Insiders hold about 31.72% of the company’s shares, while institutions hold 10.03% stake in the company. Shares short for ATAI as of 1752537600 were 16175083 with a Short Ratio of 3.78, compared to 1749772800 on 10963256. Therefore, it implies a Short% of Shares Outstanding of 16175083 and a Short% of Float of 9.790000000000001.
